Model-based drug development. [electronic resource]
Producer: 20070816Description: 21-32 p. digitalISSN:- 0009-9236
- Alzheimer Disease -- drug therapy
- Amines -- pharmacology
- Analgesics -- pharmacology
- Animals
- Anticholesteremic Agents -- pharmacology
- Bridged Bicyclo Compounds, Heterocyclic -- pharmacology
- Caproates -- pharmacology
- Cholesterol -- blood
- Clinical Trials as Topic -- legislation & jurisprudence
- Cognition -- drug effects
- Computer Simulation
- Cyclohexanecarboxylic Acids -- pharmacology
- Dose-Response Relationship, Drug
- Drug Approval
- Drug Design
- Gabapentin
- Glycoproteins -- pharmacology
- Guidelines as Topic
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- pharmacology
- Hypercholesterolemia -- blood
- Immunologic Factors -- pharmacology
- Meta-Analysis as Topic
- Models, Biological
- Models, Statistical
- Muscarinic Agonists -- pharmacology
- Neuralgia, Postherpetic -- drug therapy
- Neutrophil Infiltration -- drug effects
- Oximes -- pharmacology
- Pharmacokinetics
- Pharmacology
- Reproducibility of Results
- Research Design
- Stroke -- drug therapy
- United States
- United States Food and Drug Administration
- gamma-Aminobutyric Acid -- pharmacology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.